7.80Open6.80Pre Close1 Volume38 Open Interest73.00Strike Price780.00Turnover81.52%IV-0.14%PremiumDec 6, 2024Expiry Date7.91Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9345Delta0.0225Gamma9.99Leverage Ratio-0.1230Theta0.0050Rho9.33Eff Leverage0.0089Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet